Zhan Q - Search Results

1

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.

Wang J, Bao J, Wang R, Hong J, Zhang L, Que Q, Xu S, Wu Y, Zhan Q, Liu Y, Liu J, Zheng S, Ling S, Xu X. Wang J, et al. Among authors: zhan q. World J Surg Oncol. 2023 Mar 27;21(1):104. doi: 10.1186/s12957-023-02994-y. World J Surg Oncol. 2023. PMID: 36967432 Free PMC article.

2

USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.

Ling S, Shan Q, Zhan Q, Ye Q, Liu P, Xu S, He X, Ma J, Xiang J, Jiang G, Wen X, Feng Z, Wu Y, Feng T, Xu L, Chen K, Zhang X, Wei R, Zhang C, Cen B, Xie H, Song P, Liu J, Zheng S, Xu X. Ling S, et al. Among authors: zhan q. Gut. 2020 Jul;69(7):1322-1334. doi: 10.1136/gutjnl-2019-319616. Epub 2019 Nov 27. Gut. 2020. PMID: 31776228

3

Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria.

Ling S, Feng T, Zhan Q, Duan X, Jiang G, Shen T, Shan Q, Xu S, Ye Q, Liu P, Cen B, Zheng S, Xu X. Ling S, et al. Among authors: zhan q. Ann Transl Med. 2020 Feb;8(4):80. doi: 10.21037/atm.2020.01.10. Ann Transl Med. 2020. PMID: 32175373 Free PMC article.

4

Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.

Zhan QF, Ling SB, Deng YN, Shan QN, Ye QW, Xu SJ, Jiang GJ, Lu D, Wei XY, Zhuang L, Zhang W, Shen T, Cen BN, Xie HY, Liu JM, Wu J, Zheng SS, Yang Y, Xu X. Zhan QF, et al. Hepatobiliary Pancreat Dis Int. 2020 Aug;19(4):349-357. doi: 10.1016/j.hbpd.2020.06.011. Epub 2020 Jun 21. Hepatobiliary Pancreat Dis Int. 2020. PMID: 32622826

5

Downstaging treatment for patients with hepatocelluar carcinoma before transplantation.

Jiang G, Ling S, Zhan Q, Zhuang L, Xu X. Jiang G, et al. Among authors: zhan q. Transplant Rev (Orlando). 2021 Apr;35(2):100606. doi: 10.1016/j.trre.2021.100606. Epub 2021 Feb 5. Transplant Rev (Orlando). 2021. PMID: 33636480 Review.

6

Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy.

Xu S, Ling S, Shan Q, Ye Q, Zhan Q, Jiang G, Zhuo J, Pan B, Wen X, Feng T, Lu H, Wei X, Xie H, Zheng S, Xiang J, Shen Y, Xu X. Xu S, et al. Among authors: zhan q. Adv Sci (Weinh). 2021 Jan 15;8(5):2003042. doi: 10.1002/advs.202003042. eCollection 2021 Mar. Adv Sci (Weinh). 2021. PMID: 33717848 Free PMC article.

7

Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.

Ye Q, Ling S, Jiang G, Shan Q, Xu S, Zhan Q, Wu Y, Liu Y, Zheng S, Xu X. Ye Q, et al. Among authors: zhan q. Eur J Surg Oncol. 2021 Oct;47(10):2533-2542. doi: 10.1016/j.ejso.2021.04.001. Epub 2021 Apr 19. Eur J Surg Oncol. 2021. PMID: 33902956

8

E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.

Ling S, Zhan Q, Jiang G, Shan Q, Yin L, Wang R, Que Q, Wei X, Xu S, Yu J, Zhou W, Zhang L, Bao J, Ye Q, Su R, Wei R, Liu J, Chen K, Wang J, Xie H, Zheng S, He X, Xiang J, Xu X. Ling S, et al. Among authors: zhan q. Am J Transplant. 2022 Oct;22(10):2323-2336. doi: 10.1111/ajt.17124. Epub 2022 Jul 1. Am J Transplant. 2022. PMID: 35729702 Free article.

9

TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.

Yu J, Ling S, Hong J, Zhang L, Zhou W, Yin L, Xu S, Que Q, Wu Y, Zhan Q, Bao J, Xu N, Liu Y, Chen K, Wei X, Liu Z, Feng T, Zhou L, Xie H, Wang S, Liu J, Zheng S, Xu X. Yu J, et al. Among authors: zhan q. J Immunother Cancer. 2023 Nov 29;11(11):e007479. doi: 10.1136/jitc-2023-007479. J Immunother Cancer. 2023. PMID: 38030304 Free PMC article.

10

Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.

Ye Q, Zhou W, Xu S, Que Q, Zhan Q, Zhang L, Zheng S, Ling S, Xu X. Ye Q, et al. Among authors: zhan q. MedComm (2020). 2023 Dec 1;4(6):e439. doi: 10.1002/mco2.439. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38045832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,798 results

Search Page

Filters